Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1286

2.

Reducing mortality from emerging diseases.

[No authors listed]

Wkly Epidemiol Rec. 2015 Mar 27;90(13):121-3. English, French. No abstract available.

PMID:
25816447
3.

Immunity to influenza. Preventing infection and regulating disease.

Allen EK, Thomas PG.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):248-51. doi: 10.1164/rccm.201412-2245ED. No abstract available.

PMID:
25635487
4.

Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding.

Nita-Lazar M, Banerjee A, Feng C, Amin MN, Frieman MB, Chen WH, Cross AS, Wang LX, Vasta GR.

Mol Immunol. 2015 May;65(1):1-16. doi: 10.1016/j.molimm.2014.12.010. Epub 2015 Jan 16. Review.

PMID:
25597246
5.

Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.

He W, Mullarkey CE, Duty JA, Moran TM, Palese P, Miller MS.

J Virol. 2015 Apr;89(7):3610-8. doi: 10.1128/JVI.03099-14. Epub 2015 Jan 14.

PMID:
25589655
6.

Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus.

Pu J, Wang S, Yin Y, Zhang G, Carter RA, Wang J, Xu G, Sun H, Wang M, Wen C, Wei Y, Wang D, Zhu B, Lemmon G, Jiao Y, Duan S, Wang Q, Du Q, Sun M, Bao J, Sun Y, Zhao J, Zhang H, Wu G, Liu J, Webster RG.

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):548-53. doi: 10.1073/pnas.1422456112. Epub 2014 Dec 29.

PMID:
25548189
7.

Longevity and determinants of protective humoral immunity after pandemic influenza infection.

Sridhar S, Begom S, Hoschler K, Bermingham A, Adamson W, Carman W, Riley S, Lalvani A.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):325-32. doi: 10.1164/rccm.201410-1798OC.

PMID:
25506631
8.

[Pandemic potential of circulating avian influenza strains sharing common features with the 1918 influenza strain].

Lina B.

Med Sci (Paris). 2014 Oct;30(10):851-3. doi: 10.1051/medsci/20143010011. Epub 2014 Oct 14. French. No abstract available.

PMID:
25311019
9.

NADPH oxidases as novel pharmacologic targets against influenza A virus infection.

Vlahos R, Selemidis S.

Mol Pharmacol. 2014 Dec;86(6):747-59. doi: 10.1124/mol.114.095216. Epub 2014 Oct 9. Review.

PMID:
25301784
10.

2009 H1N1 influenza and pregnancy--5 years later.

Rasmussen SA, Jamieson DJ.

N Engl J Med. 2014 Oct 9;371(15):1373-5. doi: 10.1056/NEJMp1403496. No abstract available.

PMID:
25295498
11.

Association of age and comorbidity on 2009 influenza A pandemic H1N1-related intensive care unit stay in Massachusetts.

Placzek HE, Madoff LC.

Am J Public Health. 2014 Nov;104(11):e118-25. doi: 10.2105/AJPH.2014.302197. Epub 2014 Sep 11.

PMID:
25211746
12.

Mutations to PB2 and NP proteins of an avian influenza virus combine to confer efficient growth in primary human respiratory cells.

Danzy S, Studdard LR, Manicassamy B, Solorzano A, Marshall N, García-Sastre A, Steel J, Lowen AC.

J Virol. 2014 Nov;88(22):13436-46. doi: 10.1128/JVI.01093-14. Epub 2014 Sep 10.

13.

A universal flu vaccine.

Kesik-Brodacka M, Plucienniczak G.

Acta Biochim Pol. 2014;61(3):523-30. Epub 2014 Sep 9. Review.

14.

Native nucleic acid electrophoresis as an efficient alternative for genotyping method of influenza virus.

Pajak B, Lepek K.

Acta Biochim Pol. 2014;61(3):479-83. Epub 2014 Sep 1. Review.

15.

Antivirals--current trends in fighting influenza.

Król E, Rychłowska M, Szewczyk B.

Acta Biochim Pol. 2014;61(3):495-504. Epub 2014 Sep 1. Review.

16.

Infection of influenza virus neuraminidase-vaccinated mice with homologous influenza virus leads to strong protection against heterologous influenza viruses.

He B, Chang H, Liu Z, Huang C, Liu X, Zheng D, Fang F, Sun B, Chen Z.

J Gen Virol. 2014 Dec;95(Pt 12):2627-37. doi: 10.1099/vir.0.067736-0. Epub 2014 Aug 28.

PMID:
25170051
17.

Molecular basis of a pandemic of avian-type influenza virus.

Sriwilaijaroen N, Suzuki Y.

Methods Mol Biol. 2014;1200:447-80. doi: 10.1007/978-1-4939-1292-6_38. Review.

PMID:
25117257
18.

[Function of glycochains in virus infection].

Takahashi T.

Yakugaku Zasshi. 2014;134(8):889-99. Japanese.

19.

Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.

Isakova-Sivak I, de Jonge J, Smolonogina T, Rekstin A, van Amerongen G, van Dijken H, Mouthaan J, Roholl P, Kuznetsova V, Doroshenko E, Tsvetnitsky V, Rudenko L.

PLoS One. 2014 Jul 24;9(7):e102339. doi: 10.1371/journal.pone.0102339. eCollection 2014.

20.

Influenza and other respiratory viruses involved in severe acute respiratory disease in northern Italy during the pandemic and postpandemic period (2009-2011).

Pariani E, Martinelli M, Canuti M, Jazaeri Farsani SM, Oude Munnink BB, Deijs M, Tanzi E, Zanetti A, van der Hoek L, Amendola A.

Biomed Res Int. 2014;2014:241298. doi: 10.1155/2014/241298. Epub 2014 Jun 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk